Search

everythinglearnresearchcommunity

for

Search:↓

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Imuvert can prevent some chemotherapy-induced hair loss.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Interleukin-6 may play a role in causing alopecia areata.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

COVID-19 may harm male fertility and damage the reproductive system.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Testosterone may both worsen and protect against COVID-19 effects in men.

COVID-19 doesn't make alopecia areata worse.

Possible link between androgens and COVID-19 severity; more research needed.